Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- KARAP/DAP12
- Inhibitory and activating NKR
- Activating KIRs - paper
- DAP12 - papers
- Inhibitory and activating NKR - mechanisms
- ITAM-bearing transducing polypeptide
- Proteins with ITAM
- KIR signaling pathways
- ITAM in NK cells and macrophages
- KARAP/DAP12 associated receptors
- DAP12 association with ITAM
- DAP12 role in osteoclastogenesis
- PLOSL/Nasu-Hakola
- ITAM-bearing subunits in osteoclastogenesis
- Integration of RANK and ITAM signaling
- DAP12 role in giant cell formation
- Spontaneous fatal inflammatory syndrome (1)
- Spontaneous fatal inflammatory syndrome (2)
- Multinucleated giant cells
- Quantitation of macrophage fusion
- Impaired macrophage fusion in vitro
- DAP12 knock down reduces macrophage fusion
- DAP12 overexpression enhances fusion
- TREM-2 and Syk as examples
- The TREM2:DAP12:Syk signaling pathway
- Reduced expression of fusion mediators
- Macrophages programmed into a fusogenic state
- Impaired macrophage fusion in vivo
- Pathways of granuloma formation
- Programming into a fusion-competent state
- DAP12 cross-talks with other signaling pathways
- Integrated signaling by ITAM and TLRs
- ITAM and cytokine Jak-STAT signaling
- Activating/inhibitory pathways initiated by DAP12
- Indirect inhibition of TLR
- Receptor isotypy
- DAP12 and DAP10
- DAP12, DAP10 interaction with receptors
- Immune response adaptation
- Isotypy via differential adaptor association
- Summary
Topics Covered
- KARAP/DAP12/Tyrobp: Three names and a multiplicity of biological functions in cellular interactions
- Signal transduction
- ITAM
- Myeloid cells
- Osteoclasts
- Bone remodelling
- Giant cells formation
- Inflammation
- Natural killer cells
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Vivier, E. (2012, May 8). KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions in cellular interactions [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/NSYU5659.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Eric Vivier has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions in cellular interactions
Published on May 8, 2012
34 min
A selection of talks on Immunology & Inflammation
Hide